Green Synthesis of Metal Nanoparticles with Borojó () Extracts and Their Application in As Removal in Water Matrix.

Nanomaterials (Basel)

Departamento de Química Analítica, Química Física e Ingeniería Química, Universidad de Alcalá, Ctra. Madrid-Barcelona km 33.6, 28871 Alcalá de Henares, Madrid, Spain.

Published: September 2024

AI Article Synopsis

  • The research focused on creating a method to eliminate arsenic, a dangerous pollutant, from the Papallacta Lagoon in Ecuador, where arsenic levels reached between 18 to 652 μg/L.
  • Metallic nanoparticles such as MnO, FeO, and CuO were synthesized and tested for their effectiveness in removing arsenic, with FeO showing the highest removal rate of 87% at a concentration of 150 mg/L.
  • Various characterization techniques confirmed the properties of the nanoparticles, suggesting their potential application in water treatment facilities for the lagoon.

Article Abstract

The predominant aim of the current research was to generate a proposal for the removal of arsenic, a highly toxic pollutant, encountered within the Papallacta Lagoon in Ecuador. The average concentrations of As yielded ranges between 18 to 652 μg/L, through the use of metallic nanoparticles. Sampling was performed in the lagoon with their respective geographic locations and "in situ" parameters. Nanoparticles of MnO NPs, FeO NPs, and CuO NPs were synthesized at a 0.5 M concentration, using the precipitation method, and borojó () extract was added as an anti-caking agent as well as antioxidant. The nanoparticles were characterized by visible spectrophotometry, scanning electron microscopy (SEM), transmission electron microscopy (TEM), X-ray diffraction (XRD), and Raman spectroscopy. After arsenic removal treatment using nanoparticles, a randomized experimental design of different concentrations (5 mg/L, 10 mg/L, 25 mg/L, 50 mg/L, 100 mg/L, and 150 mg/L) was applied at laboratory level. The average diameter of FeONPs ranged from 9 nm to 36 nm, MnO NPs were 15-20 nm, and CuO NPs ranged from 25 nm to 30 nm. Arsenic removal percentages using FeO NPs with a concentration of 150 mg/L was 87%; with MnO NPs, the removal was 70% and CuO NPs of about 63.5%. Finally, these nanoparticles could be used in a water treatment plant for the Papallacta Lagoon.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11434951PMC
http://dx.doi.org/10.3390/nano14181526DOI Listing

Publication Analysis

Top Keywords

mno nps
12
cuo nps
12
mg/l mg/l
12
papallacta lagoon
8
nps
8
feo nps
8
electron microscopy
8
arsenic removal
8
150 mg/l
8
mg/l
7

Similar Publications

Mesoporous polydopamine composite nanoparticles for multimodal therapy based on disrupting the redox homeostasis within tumor cells.

J Colloid Interface Sci

December 2024

Molecular Diagnostic Center, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Hangzhou First People's Hospital, Hangzhou 310006, China. Electronic address:

Developing multimodal combination therapy strategies to disrupt the redox homeostasis within tumor cells is currently an important approach in cancer treatment. In this study, we designed and prepared multifunctional composite nanoparticles MPDA-PEG@MnO@2-DG (MPPMD NPs) utilizing mesoporous polydopamine nanoparticles (MPDA NPs) as carriers. These carriers were coated with polyethylene glycol (PEG), and manganese dioxide (MnO) and loaded with 2-deoxy-d-glucose (2-DG).

View Article and Find Full Text PDF

Influenza epidemics remain a global public health challenge. Vaccination with nucleic acid-based vaccines, which trigger strong cellular and humoral immune responses, represents a promising approach for preventing virus infection. However, its effectiveness relies on efficient delivery and an immunoadjuvant.

View Article and Find Full Text PDF

Renal Clearable Chiral Manganese Oxide Supraparticles for In Vivo Detection of Metalloproteinase-9 in Early Cancer Diagnosis.

Adv Mater

December 2024

State Key Laboratory of Food Science and Technology, International Joint Research Laboratory for Biointerface and Biodetection, School of Food Science and Technology, Jiangnan University, Wuxi, Jiangsu, 214122, China.

In this study, polypeptide TGGGPLGVARGKGGC-induced chiral manganese dioxide supraparticles (MnO SPs) are prepared for sensitive quantification of matrix metalloproteinase-9 (MMP-9) in vitro and in vivo. The results show that L-type manganese dioxide supraparticles (L-MnO SPs) exhibited twice the affinity for the cancer cell membrane receptor CD47 (cluster of differentiation, integrin-associated protein) than D-type manganese dioxide supraparticles (D-MnO SPs) to accumulate at the tumor site after surface modification of the internalizing arginine-glycine-aspartic acid (iRGD) ligand, specifically reacting with the MMP-9, disassembling into ultrasmall nanoparticles (NPs), and efficiently underwent renal clearance. Furthermore, L-MnO facilitates the quantification of MMP-9 in mouse tumor xenografts, as demonstrated by circular dichroism (CD) and magnetic resonance imaging (MRI) within 2 h.

View Article and Find Full Text PDF

Sunlight-driven photocatalytic degradation of industrial dyes using Withania somnifera decorated MnO nanoparticles.

Discov Nano

December 2024

Department of Chemistry, School of Applied and Life Sciences, Uttaranchal University, Dehradun, Uttarakhand, 248007, India.

Article Synopsis
  • The study introduces a quick and eco-friendly method to create manganese oxide (MnO) nanoparticles using Ashwagandha extract, with noticeable color change signaling synthesis.
  • Various analytical techniques confirmed the formation and properties of the nanoparticles, which demonstrated high photocatalytic efficiency in breaking down pollutants when exposed to sunlight.
  • The process is simple, does not require harmful chemicals, and has potential applications in wastewater treatment, promoting the development of sustainable nanomaterials.
View Article and Find Full Text PDF

Capsaicin-induced Ca overload and ablation of TRPV1-expressing axonal terminals for comfortable tumor immunotherapy.

Nanoscale

December 2024

Institute of Rehabilitation Medicine, School of Rehabilitation Medicine, Binzhou Medical University, Yantai 264003, People's Republic of China.

As a common malignancy symptom, cancer pain significantly affects patients' quality of life. Approximately 60%-90% of patients with advanced cancer experience debilitating pain. Therefore, a comprehensive treatment system that combines cancer pain suppression and tumor treatment could provide significant benefits for these patients.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!